PAs may have lower diagnostic accuracy for melanoma

April 20, 2018

(HealthDay)—Physician assistants (PAs) perform more skin biopsies per case of skin cancer diagnosed and diagnose fewer melanomas in situ than dermatologists, according to a study published online April 18 in JAMA Dermatology.

Alyce M. Anderson, Ph.D., from the University of Pittsburgh School of Medicine, and colleagues compared the for skin cancer of PAs with that of dermatologists. Medical records were reviewed for 33,647 skin cancer screening examinations in 20,270 unique patients.

The researchers found that the number needed to biopsy (NNB) to diagnose one case of skin cancer was 3.9 for PAs and 3.3 for dermatologists (P < 0.001). Per diagnosed melanoma, the NNB was 39.4 and 25.4 for PAs and dermatologists, respectively (P = 0.007). Compared with those screened by a , patients screened by a PA were significantly less likely to be diagnosed with melanoma in situ (1.1 versus 1.8 percent of visits; P = 0.02); for invasive melanoma (0.7 versus 0.8 percent of visits; P = 0.83) and nonmelanoma (6.1 versus 6.1 percent of visits; P = 0.98), the differences were not significant.

"Although the availability of PAs may help increase access to care and reduce waiting times for appointments, these findings have important implications for the training, appropriate scope of practice, and supervision of PAs and other nonphysician practitioners in dermatology," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further: Early skin cancer more accurately diagnosed by dermatologist than other providers

More information: Abstract/Full Text

Related Stories

Early skin cancer more accurately diagnosed by dermatologist than other providers

April 18, 2018
Physician assistants (PAs) are increasingly used in dermatology practices to cut costs and improve access to care, but are more likely than dermatologists to perform unnecessary skin biopsies to check for cancer, while being ...

Large-scale skin cancer screening initiative feasible

February 25, 2017
(HealthDay)—Large-scale skin cancer screening, including full-body skin examination (FBSE) is feasible and increases diagnosis of melanoma and thinner invasive melanoma, according to a study published online Feb. 23 in ...

Hydrochlorothiazide tied to non-melanoma skin cancer risk

March 22, 2018
(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy ...

Spouses can boost early detection for melanoma patients

April 18, 2018
There's an extra bonus to marriage for melanoma patients: They tend to be diagnosed in earlier more treatable stages than patients who are unmarried, widowed or divorced, a new study says.

Similar skin cancer incidence seen with teledermatology

June 26, 2017
(HealthDay)—The incidence of skin cancer is similar for patients evaluated by store-and-forward (SAF) teledermatology or face-to-face (F2F) consultation, according to a study published online June 20 in the International ...

AAD: Older men should screen themselves for skin cancer

March 1, 2013
(HealthDay)—Men aged 50 years or older are more likely to be diagnosed with invasive melanoma by a dermatologist than to detect it themselves; and they are less likely to seek a skin cancer screening due to a suspicious ...

Recommended for you

A code for reprogramming immune sentinels

December 10, 2018
For the first time, a research team at Lund University in Sweden has successfully reprogrammed mouse and human skin cells into immune cells called dendritic cells. The process is quick and effective, representing a pioneering ...

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Major breakthrough in quest for cancer vaccine

December 6, 2018
The idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove exactly how such a vaccine would work.

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Scientists develop new technology for profiling unique genetic makeup of myeloma tumor cells

December 6, 2018
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells—outlining how cancer cells hijack specific pathways for uncontrolled proliferation—will lead to more efficient ways to fight it. Joint ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.